Healthcare provider profile · identity verified

Pavan K Janapati, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · LAS VEGAS, NV · NPI 1467535070

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Pavan K Janapati, M.D. received $152.45 in general payments during 2025 across 4 reported records.

SK Life Science, Inc. accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$152.45

4 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
SK Life Science, Inc.	SK Life Science, Inc. exact · evidence 2025-04-03	$152.45	100.0%	4	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$152.45	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	801	193
Eliquis	Apixaban	688	84
Amlodipine Besylate	Amlodipine Besylate	456	100
Gabapentin	Gabapentin	445	90
Levothyroxine Sodium	Levothyroxine Sodium	432	76
Pantoprazole Sodium	Pantoprazole Sodium	285	79
Tamsulosin Hcl	Tamsulosin Hcl	249	58
Donepezil Hcl	Donepezil Hcl	248	41
Metoprolol Tartrate	Metoprolol Tartrate	240	59
Clopidogrel	Clopidogrel Bisulfate	227	41
Famotidine	Famotidine	225	49
Levetiracetam	Levetiracetam	213	41
Lisinopril	Lisinopril	209	58
Losartan Potassium	Losartan Potassium	207	58
Trazodone Hcl	Trazodone Hcl	196	45
Metformin Hcl	Metformin Hcl	187	43
Furosemide	Furosemide	182	52
Carvedilol	Carvedilol	177	50
Hydralazine Hcl	Hydralazine Hcl	160	48
Sertraline Hcl	Sertraline Hcl	155	33
Omeprazole	Omeprazole	147	31
Buspirone Hcl	Buspirone Hcl	143	29
Hydroxyzine Hcl	Hydroxyzine Hcl	130	35
Duloxetine Hcl	Duloxetine Hcl	129	24
Memantine Hcl	Memantine Hcl	128	28
Potassium Chloride	Potassium Chloride	122	36
Insulin Lispro Kwikpen U-100	Insulin Lispro	120	33
Jardiance	Empagliflozin	118	suppressed
Risperidone	Risperidone	116	25
Divalproex Sodium	Divalproex Sodium	111	26
Quetiapine Fumarate	Quetiapine Fumarate	110	27
Mirtazapine	Mirtazapine	101	29
Clonidine Hcl	Clonidine Hcl	100	28
Enoxaparin Sodium	Enoxaparin Sodium	99	13
Midodrine Hcl	Midodrine Hcl	95	29
Escitalopram Oxalate	Escitalopram Oxalate	92	27
Januvia	Sitagliptin Phosphate	90	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	17
Xarelto	Rivaroxaban	80	13
Metoprolol Succinate	Metoprolol Succinate	78	21
Methocarbamol	Methocarbamol	76	16
Finasteride	Finasteride	72	18
Benztropine Mesylate	Benztropine Mesylate	71	suppressed
Montelukast Sodium	Montelukast Sodium	71	15
Heparin Sodium	Heparin Sodium,porcine	69	14
Novolog Flexpen	Insulin Aspart	69	11
Fluoxetine Hcl	Fluoxetine Hcl	66	11
Oxybutynin Chloride	Oxybutynin Chloride	63	15
Simvastatin	Simvastatin	63	12
Ibuprofen	Ibuprofen	62	14
Humalog Kwikpen U-100	Insulin Lispro	59	13
Primidone	Primidone	59	suppressed
Megestrol Acetate	Megestrol Acetate	56	15
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	52	27
Ondansetron Hcl	Ondansetron Hcl	52	27
Citalopram Hbr	Citalopram Hydrobromide	51	14
Lamotrigine	Lamotrigine	50	suppressed
Allopurinol	Allopurinol	49	12
Hydrochlorothiazide	Hydrochlorothiazide	47	suppressed
Amiodarone Hcl	Amiodarone Hcl	45	12
Aripiprazole	Aripiprazole	45	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	45	suppressed
Baclofen	Baclofen	44	15
Nifedipine Er	Nifedipine	44	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	43	16
Insulin Aspart Flexpen	Insulin Aspart	43	11
Spironolactone	Spironolactone	43	15
Alendronate Sodium	Alendronate Sodium	42	suppressed
Entresto	Sacubitril/Valsartan	41	suppressed
Glipizide	Glipizide	41	13
Sevelamer Carbonate	Sevelamer Carbonate	41	suppressed
Lactulose	Lactulose	40	14
Trulicity	Dulaglutide	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	11
Olanzapine	Olanzapine	38	suppressed
Sodium Chloride	0.9 % Sodium Chloride	37	20
Carbidopa-Levodopa	Carbidopa/Levodopa	36	14
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Meclizine Hcl	Meclizine Hcl	34	suppressed
Divalproex Sodium Er	Divalproex Sodium	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	31	13
Meloxicam	Meloxicam	30	suppressed
Myrbetriq	Mirabegron	30	suppressed
Sucralfate	Sucralfate	30	suppressed
Ampicillin-Sulbactam	Ampicillin Sod/Sulbactam Sod	28	suppressed
Atenolol	Atenolol	28	suppressed
Budesonide	Budesonide	28	12
Latanoprost	Latanoprost	27	suppressed
Meropenem	Meropenem	27	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	26	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	26	suppressed
Levemir Flexpen	Insulin Detemir	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Brilinta	Ticagrelor	23	suppressed
Lubiprostone	Lubiprostone	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	12
Nystop	Nystatin	22	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	12
Glimepiride	Glimepiride	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Calcitriol	Calcitriol	19	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	19	12
Azithromycin	Azithromycin	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Prednisone	Prednisone	18	suppressed
Tacrolimus	Tacrolimus	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Dapagliflozin	Dapagliflozin Propanediol	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Dulera	Mometasone/Formoterol	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Ozempic	Semaglutide	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Naproxen	Naproxen	16	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Fenofibrate	Fenofibrate	15	suppressed
Novolin R Flexpen	Insulin Regular, Human	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Albuterol Sulfate	Albuterol Sulfate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Zosyn	Piperacillin-Tazo-Dextrose,iso	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Digoxin	Digoxin	13	suppressed
Estradiol	Estradiol	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Topiramate	Topiramate	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Balsalazide Disodium	Balsalazide Disodium	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Cefepime Hcl	Cefepime Hcl	11	suppressed
Cephalexin	Cephalexin	11	11
Clozapine	Clozapine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Tobramycin Sulfate	Tobramycin Sulfate	11	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$152.45 · 4 records	SK Life Science, Inc.	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error